EAU 2014 - Poster: Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase and prostate-specific antigen in patients with castration-resistant prostate cancer and symptomatic bone metastases from the phase 3 ALSYMPCA trial

STOCKHOLM, SWEDEN (UroToday.com) - Presented by D. Heinrich,1 C. Parker,2 M. Shan,3 S. Wilhelm,3 M. Wahba,3 J. Garcia-Vargas,3 C.G. O’Bryan-Tear,4 O. Sartor5 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Heinrich EAU 2014 thumb

1Akershus University Hospital, Lørenskog, Norway; 2The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK; 3Bayer HealthCare, Whippany, NJ, USA; 4Algeta ASA, Oslo, Norway; 5Tulane University Cancer Center, New Orleans, LA, USA

Click HERE to read an exclusive report by a UroToday medical writer

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Annual Virtual Meeting / Oct 17
  • 2020 Annual Congress / October 10 - 11
  • 2020 Annual Meeting / October 1-3
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland